Paragon Biosciences is quickly becoming a well-known name in the pharmaceutical field. They have a record 13 FDA approved drugs on the market in only a decade’s worth of time. This much success is most commonly associated with much bigger companies. The rate of success only proves that they are here to stay and make it known that they mean business. This is a very good thing for us. Paragon Biosciences has the same fundamental values in its veins as the CEO and Chairman, Jeff Aronin. They value patients above anything else. It shows not only with the amazing success they have already had, but the success they are continuing to achieve. Paragon Biosciences is specializing in nervous system disorders, rare genetic diseases, dermatology and many more. Having multiple projects in the works, it won’t be long until we hear of a new breakthrough (https://about.me/jeffaronin). With the achievements that have already been met, the patients and industry can only wait to see what other groundbreaking development comes from Paragon Biosciences.
Knowing that medicine and healthcare was his chosen path, Jeff Aronin figured out his calling early into his career. Having more than 20 years in the medical industry, his drive to cure and comfort his patients is what got him to where he is now. After becoming an entrepreneur, Jeff Aronin not only has a passion for his patients, his knowledge and expertise in rare diseases are what make him an asset to the industry. Jeff Aronin won multiple awards for entrepreneurship and patient oriented work, his dedication and research for cures has not dwindled. He’s consistently striving to find the problems in healthcare and come up with a solution for them. His record breaking company is proof to his dedication and commitment to the industry. Being able to build and maintain the highest of standards is important for a company in any field. Jeff Aronin and Paragon Biosciences has managed to not only maintain those standards, but exceed them in so many ways. We expect to see many more success stories from Jeff Aronin and his successful company, Paragon Biosciences.